Plain-English translation of NCT02379429 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Bladder Cancer research guide →Researchers are collecting blood, urine, and tissue samples from people diagnosed with bladder cancer (also called urothelial cancer) and from healthy volunteers. By studying these samples, scientists hope to understand what causes bladder cancer to develop and to discover new, targeted treatments that work better than current options.
Bladder cancer hasn't seen major advances in treatment in over 20 years, and it remains very expensive to treat. This study exists to uncover the genetic and molecular changes that drive the disease, similar to successful approaches that led to new kidney cancer drugs.
You likely qualify if…
You likely don't qualify if…
If you have bladder cancer, researchers will collect your blood, urine, and tissue samples during your regular diagnostic or treatment visits—no extra appointments are needed. If you are a healthy volunteer, you'll donate blood, saliva, and urine samples once. All samples are used to study the disease and find new treatments, and researchers will follow your health outcomes over time to understand how the cancer progresses.
AI-generated summary from trial data · Jun 7, 2026 · Not medical advice
United States